These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20430500)
21. Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid. Ozdemir O; Yakut A; Dinleyici EC; Aydogdu SD; Yarar C; Colak O Eur J Pediatr; 2011 Jul; 170(7):873-7. PubMed ID: 21140275 [TBL] [Abstract][Full Text] [Related]
22. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate. Henning BF; Zidek W; Riezler R; Graefe U; Tepel M Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667 [TBL] [Abstract][Full Text] [Related]
23. Homocysteine and C-reactive protein levels in haemodialysis patients. Koulouridis E; Tzilianos M; Katsarou A; Costimba I; Klonou E; Panagiotaki E; Georgalidis C; Krokida A; Delaportas N; Lachanas A; Karaliotas G; Kaliolia I Int Urol Nephrol; 2001; 33(2):207-15. PubMed ID: 12092633 [TBL] [Abstract][Full Text] [Related]
24. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059 [TBL] [Abstract][Full Text] [Related]
25. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events. Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173 [TBL] [Abstract][Full Text] [Related]
26. The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis. Ziakka S; Rammos G; Kountouris S; Doulgerakis C; Karakasis P; Kourvelou C; Papagalanis N Int Urol Nephrol; 2001; 33(3):559-62. PubMed ID: 12230295 [TBL] [Abstract][Full Text] [Related]
27. No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk. Spoelstra-de Man AM; Teerlink T; Brouwer CB; Rauwerda JA; Stehouwer CD; Smulders YM Clin Endocrinol (Oxf); 2006 May; 64(5):495-501. PubMed ID: 16649966 [TBL] [Abstract][Full Text] [Related]
28. Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke. Xia XS; Li X; Wang L; Wang JZ; Ma JP; Wu CJ J Clin Neurosci; 2014 Sep; 21(9):1586-90. PubMed ID: 24814858 [TBL] [Abstract][Full Text] [Related]
29. Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid. Chiarello PG; Vannucchi MT; Moysés Neto M; Vannucchi H Int J Vitam Nutr Res; 2003 Nov; 73(6):431-8. PubMed ID: 14743547 [TBL] [Abstract][Full Text] [Related]
30. Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease. van Guldener C; Nanayakkara PW; Stehouwer CD Clin Chem Lab Med; 2007; 45(12):1683-7. PubMed ID: 17937610 [TBL] [Abstract][Full Text] [Related]
31. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation]. Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000 [TBL] [Abstract][Full Text] [Related]
32. Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease. Ziegler S; Mittermayer F; Plank C; Minar E; Wolzt M; Schernthaner GH J Clin Endocrinol Metab; 2005 Apr; 90(4):2175-8. PubMed ID: 15634723 [TBL] [Abstract][Full Text] [Related]
33. Folic acid and pyridoxal-5'-phosphate losses during high-efficiency hemodialysis in patients without hydrosoluble vitamin supplementation. Leblanc M; Pichette V; Geadah D; Ouimet D J Ren Nutr; 2000 Oct; 10(4):196-201. PubMed ID: 11070147 [TBL] [Abstract][Full Text] [Related]
34. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Heinz J; Kropf S; Luley C; Dierkes J Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080 [TBL] [Abstract][Full Text] [Related]